EUVIMEDEUVIMED entdecken
Crossref

RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1

Lin Yuan, Shichen Bu, Meng Du, Yilong Wang, Chenhui Ju, Dandan Huang, Wenjing Xu, Xin Tan, Minglu Liang, Shan Deng, Liu Yang iD, Kai Huang

Cardiovascular Research · 17.03.2023 · 119 (1) · 183-194

DOI: 10.1093/cvr/cvac039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 30.03.2022. Verfasst von Lin Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, Hube…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Signal Transduction. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The heart undergoes pathological remodelling, featured by the hypertrophic growth of cardiomyocytes and increased cardiac fibrosis, under biomechanical stress such as haemodynamic overload. Ring Finger Protein 207 (RNF207) is an E3 ubiquitin ligase that is predominantly expressed in the heart, but its function remains elusive. In this study, we aimed to explore the role of RNF207 in the development of pathological cardiac hypertrophy and dysfunction. Methods and results Transverse aortic constriction (TAC) surgery was performed on mice to induce cardiac hypertrophy. Cardiac function and remodelling were evaluated by echocardiography, histological assessment, and molecular analyses. Our data indicated that RNF207 overexpression (OE) exacerbated cardiac hypertrophy, fibrosis, and systolic dysfunction. In contrast, TAC-induced cardiac remodelling was profoundly blunted in RNF207 knockdown (KD) hearts. In line with the in vivo findings, RNF207 OE augmented, whereas RNF207 KD alleviated, phenylephrine-induced cardiomyocyte hypertrophy in vitro. Mechanistically, we demonstrated that RNF207 elicited detrimental effects by promoting K63-linked ubiquitination of TAK1-binding protein 1 (TAB1), which triggered the autophosphorylation of transforming growth factor-β activated kinase 1 (TAK1) and the activation of downstream p38 and c-Jun N-terminal kinase (JNK)1/2 signalling pathways. In the TAB1-KD cardiomyocytes, RNF207-OE-induced cell hypertrophy was significantly attenuated, indicating that RNF207-induced hypertrophy is, at least in part, TAB1-dependent.

Conclusions

This study demonstrates that RNF207 exacerbates pressure overload-induced cardiac hypertrophy and dysfunction via post-translational modification of TAB1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisSignal TransductionAnimalsMiceCardiomegalyCells, CulturedDisease Models, AnimalMice, Inbred C57BLMice, KnockoutMyocytes, CardiacUbiquitinationUbiquitin-Protein LigasesAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

Cardiac hypertrophyCell signallingHeart failure

Substanzen

Ubiquitin-Protein LigasesTab1 protein, mouseAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, Hubei, China.
  • Clinic Center of Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.
  • Department of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Guangzhou, Guangdong, China.
  • Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Liu Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yuan, L., Bu, S., Du, M., Wang, Y., Ju, C., Huang, D., Xu, W., Tan, X., Liang, M., Deng, S., Yang, L., & Huang, K. (2023). RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovascular Research, 119(1), 183-194. https://doi.org/10.1093/cvr/cvac039

Vancouver

Yuan L, Bu S, Du M, Wang Y, Ju C, Huang D, et al. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovascular Research. 2023;119(1):183-194. doi:10.1093/cvr/cvac039

BibTeX
@article{Yuan2023,
  author = {Yuan, Lin and Bu, Shichen and Du, Meng and Wang, Yilong and Ju, Chenhui and Huang, Dandan and Xu, Wenjing and Tan, Xin and Liang, Minglu and Deng, Shan and Yang, Liu and Huang, Kai},
  title = {RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {1},
  pages = {183--194},
  doi = {10.1093/cvr/cvac039}
}
Kostenlos starten →